Cargando…
The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection
PURPOSE: We investigated the influence of amoxicillin pre-exposure on treatment outcomes, Chlamydia trachomatis (CT) culture, the presence of drug-resistant genes, minimum inhibitory concentrations (MICs), and fractional inhibitory concentrations (FICs) in CT clinical strains. Additionally, we explo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257477/ https://www.ncbi.nlm.nih.gov/pubmed/37305735 http://dx.doi.org/10.2147/IDR.S410410 |
_version_ | 1785057310495735808 |
---|---|
author | You, Cong Liao, Mingyi Wang, Mei Zhao, Leran Li, Longnian Ye, Xiaoying Yang, Tao |
author_facet | You, Cong Liao, Mingyi Wang, Mei Zhao, Leran Li, Longnian Ye, Xiaoying Yang, Tao |
author_sort | You, Cong |
collection | PubMed |
description | PURPOSE: We investigated the influence of amoxicillin pre-exposure on treatment outcomes, Chlamydia trachomatis (CT) culture, the presence of drug-resistant genes, minimum inhibitory concentrations (MICs), and fractional inhibitory concentrations (FICs) in CT clinical strains. Additionally, we explored the effect of different antimicrobial combinations on CT. PATIENTS AND METHODS: Clinical data of 62 patients with CT infection were recorded. Of these, 33 had pre-exposure to amoxicillin and 29 did not. Among patients with pre-exposure, 17 received azithromycin and 16 received minocycline. Among the patients without pre-exposure, 15 received azithromycin and 14 received minocycline. All patients underwent microbiological cure follow-ups one month after completing the treatment. 23S rRNA gene mutations, acquisition of tet(M) and tet(C) were detected using reverse transcription PCR (RT-PCR) and PCR, respectively. The MICs and FICs of azithromycin, minocycline, and moxifloxacin, alone or in combination, were determined using the microdilution and checkerboard methods, respectively. RESULTS: More cases of treatment failure occurred in pre-exposed patients, in both treatment groups (P <0.05). No 23S rRNA gene mutations or tet(M) and tet(C) acquisitions were found. More inclusion bodies were cultured from patients without amoxicillin pre-exposure than from those with pre-exposure (P <0.0001). The MICs of all antibiotics were higher in pre-exposed patients than in those without pre-exposure (P <0.01). The FICs of azithromycin plus moxifloxacin were lower than those of the other antibiotic combinations (P <0.0001). The synergy rate of azithromycin plus moxifloxacin was significantly higher than those of azithromycin plus minocycline and minocycline plus moxifloxacin (P <0.001). The FICs of all antibiotic combinations were comparable between isolates from the two patient groups (all P >0.05). CONCLUSION: Pre-exposure to amoxicillin in CT patients may inhibit CT growth and decrease sensitivity of CT strains to antibiotics. Azithromycin plus moxifloxacin may be a promising treatment regimen for genital CT infections with treatment failure. |
format | Online Article Text |
id | pubmed-10257477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-102574772023-06-11 The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection You, Cong Liao, Mingyi Wang, Mei Zhao, Leran Li, Longnian Ye, Xiaoying Yang, Tao Infect Drug Resist Original Research PURPOSE: We investigated the influence of amoxicillin pre-exposure on treatment outcomes, Chlamydia trachomatis (CT) culture, the presence of drug-resistant genes, minimum inhibitory concentrations (MICs), and fractional inhibitory concentrations (FICs) in CT clinical strains. Additionally, we explored the effect of different antimicrobial combinations on CT. PATIENTS AND METHODS: Clinical data of 62 patients with CT infection were recorded. Of these, 33 had pre-exposure to amoxicillin and 29 did not. Among patients with pre-exposure, 17 received azithromycin and 16 received minocycline. Among the patients without pre-exposure, 15 received azithromycin and 14 received minocycline. All patients underwent microbiological cure follow-ups one month after completing the treatment. 23S rRNA gene mutations, acquisition of tet(M) and tet(C) were detected using reverse transcription PCR (RT-PCR) and PCR, respectively. The MICs and FICs of azithromycin, minocycline, and moxifloxacin, alone or in combination, were determined using the microdilution and checkerboard methods, respectively. RESULTS: More cases of treatment failure occurred in pre-exposed patients, in both treatment groups (P <0.05). No 23S rRNA gene mutations or tet(M) and tet(C) acquisitions were found. More inclusion bodies were cultured from patients without amoxicillin pre-exposure than from those with pre-exposure (P <0.0001). The MICs of all antibiotics were higher in pre-exposed patients than in those without pre-exposure (P <0.01). The FICs of azithromycin plus moxifloxacin were lower than those of the other antibiotic combinations (P <0.0001). The synergy rate of azithromycin plus moxifloxacin was significantly higher than those of azithromycin plus minocycline and minocycline plus moxifloxacin (P <0.001). The FICs of all antibiotic combinations were comparable between isolates from the two patient groups (all P >0.05). CONCLUSION: Pre-exposure to amoxicillin in CT patients may inhibit CT growth and decrease sensitivity of CT strains to antibiotics. Azithromycin plus moxifloxacin may be a promising treatment regimen for genital CT infections with treatment failure. Dove 2023-06-06 /pmc/articles/PMC10257477/ /pubmed/37305735 http://dx.doi.org/10.2147/IDR.S410410 Text en © 2023 You et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research You, Cong Liao, Mingyi Wang, Mei Zhao, Leran Li, Longnian Ye, Xiaoying Yang, Tao The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection |
title | The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection |
title_full | The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection |
title_fullStr | The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection |
title_full_unstemmed | The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection |
title_short | The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection |
title_sort | effect of amoxicillin pre-exposure on treatment outcomes and antimicrobial susceptibility in patients with urogenital chlamydia trachomatis infection |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257477/ https://www.ncbi.nlm.nih.gov/pubmed/37305735 http://dx.doi.org/10.2147/IDR.S410410 |
work_keys_str_mv | AT youcong theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT liaomingyi theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT wangmei theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT zhaoleran theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT lilongnian theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT yexiaoying theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT yangtao theeffectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT youcong effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT liaomingyi effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT wangmei effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT zhaoleran effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT lilongnian effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT yexiaoying effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection AT yangtao effectofamoxicillinpreexposureontreatmentoutcomesandantimicrobialsusceptibilityinpatientswithurogenitalchlamydiatrachomatisinfection |